N-Acetylcysteine (NAC) Tablet Dosing for Acetaminophen Overdose
For oral acetylcysteine treatment of acetaminophen overdose, administer a loading dose of 140 mg/kg followed by 70 mg/kg every 4 hours for 17 additional doses (total 72-hour protocol), ideally initiated within 8 hours of ingestion to maximize hepatoprotection. 1
Immediate Treatment Algorithm
Step 1: Initiate Treatment Without Delay
- Start NAC immediately if ≤24 hours have elapsed from ingestion, regardless of acetaminophen level availability 1
- Do not wait for laboratory confirmation when acetaminophen overdose is suspected 2, 3
- The critical window is 0-8 hours post-ingestion, where severe hepatotoxicity develops in only 2.9% of treated patients 3
Step 2: Gastrointestinal Decontamination (If Applicable)
- Administer activated charcoal 1 g/kg (50g standard adult dose) if patient presents within 4 hours of ingestion 2, 4
- If activated charcoal was given, perform gastric lavage before starting NAC, as charcoal adsorbs acetylcysteine and may reduce effectiveness 1
- Do not delay NAC administration even if charcoal has been given 2
Step 3: Standard Oral NAC Protocol
Loading Dose:
- 140 mg/kg orally as a single dose 2, 1
- Dilute 20% NAC solution to 5% concentration using diet cola or diet soft drink 1
- If using gastric tube, water may be used as diluent 1
Maintenance Doses:
- 70 mg/kg every 4 hours for 17 additional doses 2, 1
- Total treatment duration: 72 hours 1
- First maintenance dose given 4 hours after loading dose 1
Risk Stratification Using Rumack-Matthew Nomogram
When to Use the Nomogram
- Single acute ingestion with known time of ingestion 5, 3
- Acetaminophen level drawn 4-24 hours post-ingestion 5, 3
- The nomogram does NOT apply to: repeated supratherapeutic ingestions, extended-release formulations, or presentations >24 hours post-ingestion 3
Treatment Decisions Based on Nomogram
- Administer NAC if level plots at or above the "possible toxicity" line 5, 2
- Do NOT administer NAC if level clearly falls below the treatment line in low-risk patients 5
- For high-risk patients (chronic alcohol use, fasting, enzyme-inducing drugs), treat even with levels in "non-toxic" range 2, 3
Special Clinical Scenarios Requiring Mandatory Treatment
Treat Immediately Regardless of Nomogram:
- Established hepatic failure from acetaminophen (reduces mortality from 80% to 52%) 2, 3
- Elevated transaminases (AST/ALT >50 IU/L) with suspected acetaminophen exposure 3
- Unknown time of ingestion with detectable acetaminophen levels 2, 3
- Extended-release acetaminophen formulations 2, 3
- Repeated supratherapeutic ingestions: ≥10g or 200 mg/kg per 24 hours, or ≥6g or 150 mg/kg per 24 hours for ≥48 hours 3
High-Risk Populations Requiring Lower Treatment Threshold:
- Chronic alcohol users: treat even with "non-toxic" levels, as hepatotoxicity occurs with doses as low as 4g/day 3
- Patients taking enzyme-inducing medications 3
- Prolonged fasting states 2
Treatment Efficacy by Timing
Optimal Window (0-8 hours):
Acceptable Window (8-10 hours):
Late Treatment (10-24 hours):
- Severe hepatotoxicity rate: 26.4% 3
- Still provides significant benefit compared to no treatment (58% hepatotoxicity in untreated patients) 5
Very Late Presentation (>24 hours):
- NAC should still be administered—it reduces mortality and hepatotoxicity even with delayed treatment 2, 3
- Treatment decisions based on acetaminophen levels, liver function tests, and clinical presentation rather than nomogram 3
Managing Treatment Complications
Vomiting (Common Adverse Effect):
- If patient vomits within 1 hour of any dose, repeat that dose 1
- Dilution to 5% concentration minimizes vomiting propensity 1
- For persistent vomiting, consider duodenal intubation for administration 1
- Nausea and vomiting are expected adverse effects of oral NAC 1
Other Adverse Effects:
- Generalized urticaria (rare): discontinue only if allergic symptoms cannot be controlled 1
- Rash with or without mild fever (rare) 1
Monitoring During Treatment
Baseline Laboratory Studies:
- Acetaminophen level 1
- AST, ALT, bilirubin 1
- Prothrombin time/INR 1
- Creatinine, BUN 1
- Blood glucose, electrolytes 1
Serial Monitoring:
- Repeat AST, ALT, bilirubin, PT/INR, creatinine, BUN, glucose, and electrolytes daily if acetaminophen level is in toxic range 1
- For extended-release formulations, obtain serial acetaminophen levels as late increases may occur at 14 hours or beyond 3
When to Discontinue or Extend NAC
Criteria for Stopping at 72 Hours:
Mandatory Extended Treatment Beyond 72 Hours:
- Delayed presentation (>24 hours post-ingestion) 3
- Extended-release acetaminophen 2, 3
- Repeated supratherapeutic ingestions 3
- Any elevation in AST or ALT above normal 3
- Rising transaminases 3
- Any coagulopathy present 3
- Detectable acetaminophen levels 3
Critical Red Flags Requiring Immediate ICU Transfer:
- AST/ALT >1000 IU/L (severe hepatotoxicity) 3
- Coagulopathy development 3
- Contact liver transplant center immediately for any evidence of liver failure 3
Critical Pitfalls to Avoid
- Never delay NAC while awaiting acetaminophen levels if strong suspicion exists 2
- Do not assume low/absent acetaminophen levels rule out poisoning if ingestion was remote or occurred over several days 3
- Do not stop NAC at 72 hours if any red flags are present (elevated transaminases, coagulopathy, detectable acetaminophen) 3
- Remember that even therapeutic doses (4g/day for 14 days) can cause ALT elevations >3x normal in 31-41% of healthy adults 3
- For chronic alcohol users, treat even with "non-toxic" nomogram levels 3